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Abstract
Background: Glucose is associated with weight gain, which increases the risk of cancer. There is insufficient
information on the effects of high glucose concentrations on cell lines. This study evaluated the viability patterns of
human cancer and normal cell lines treated with glucose. Methods: Human gingival fibroblast (hGF), colorectal
adenocarcinoma (HT29), and skin malignant melanoma (A375) cell lines were cultured and treated with additional
glucose in three respective concentrations: 1 mg/ml, 5 mg/ml, and 10 mg/ml. Then, cell viability was measured using an
MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)-assay. The data were analyzed using the
Statistical Package for the Social Sciences software. Results: The hGF cells’ percentage pattern of viability showed a
rapid decline of nearly 95% on the third day of treatment. Both HT29 and A375 were able to survive in the high glucose
condition when the cell viability percentage was above 100% on Day 5. The data exhibited significance; the p-value
was less than 0.001. Conclusion: The high glucose concentration can be toxic to hGF. In addition, HT29 and A375
might be adaptive to the hyperglycaemic condition.
Keywords: in vitro technique, fibroblasts, adenocarcinoma, malignant melanoma, glucose, cancer

factors can increase the risk of several cancers, such as
colorectal, prostate, and breast.6

Introduction
Physiologically, DNA quality is checked and verified by
a complex set of rules and restrictions during cell
division.1 The control mechanism in the body can
malfunction, forming cancer cells.2 Cancer constitutes a
large number of diseases that are characterized by
abnormal cell development, which divide uncontrollably
and can infiltrate and destroy normal body tissues.3
Cancer pathophysiology is very complex; however, a
common feature of normal and cancer cells is that both
consume sugar as one of their energy sources.2

To date, no conclusive evidence has linked sugar or any
monosaccharides directly to cancer; nonetheless, excessive
sugar consumption may alter the body’s physiology,
indirectly increasing the likelihood of cancer. A variety
of sweeteners or simple sugars is commercially
available on the market. Excessive sugar consumption
has long been associated with diabetes. However, there
is a paucity of information on whether or not glucose
can cause cancer, hindering scientists from identifying
the best management or treatment of cancer. To seek
treatment for cancer, it is crucial to have information on
the behavior and pattern of cancer cell growth. This
study investigated the viability pattern of human cancer
and normal cell lines treated with glucose at three
different concentrations which are 1 mg/mL, 5 mg/mL,
and 10 mg/mL.

Sugar is an essential source of energy for the body’s
cellular activities. In association with other factors, such
as a sedentary lifestyle, an uncontrolled sugary diet
could be one reason behind body mass index increases.4
Excessive sugar intake does not benefit the body since it
may be converted into fat, causing overweight and
obesity. Fat is very important since it helps maintain the
production of hormones and growth factors in the
body.5 Nevertheless, overproduction of these hormones
and growth factors will enhance cancer cell growth.
Only one study has reported that high-level growth

Methods
Selection and preparation of cancer and normal cell
lines. Three types of cell lines were used in this study:
57
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human colorectal adenocarcinoma (HT-29, ATCC
HTB-38, USA), human malignant melanoma (A375,
ATCC CRL-1619, USA), and human gingival fibroblast
(HGF-1, ATCC CRL-2014, USA).
Selection of monosaccharide. The monosaccharide
used in this study was glucose, procured from a supplier
in powder form.
Optimization of concentration and treatment periods.
The optimization of concentration and treatment periods
of this in vitro stability study followed a modified
version of that of Shahbuddin (2014).7 Glucose was
diluted properly in three different concentrations: 1
mg/mL, 5 mg/mL, and 10 mg/mL. The glucose was
dissolved completely in the Dulbecco’s Modified Eagle
Medium (DMEM) to remove the possibility of all
physical effects on the cell lines. This study’s DMEM
control contained only 10% of fetal bovine serum (FBS)
and 1% of an antibiotic solution. In this study, four
different incubation periods (1, 3, 5, and 10 days) were
applied as treatment parameters of the effects of glucose
on the tested cell lines’ viability. The incubation time
involved a process of doubling time, which ensured that
the data showed the cell lines’ constant growth.
Cell culture technique. The cells (HT-29, A375, and
HGF-1) were thawed and revived in a 25-ml culture
flask containing basal medium and incubated overnight
at an optimum temperature of 37 ℃, with 5% of CO2
and 90% humidity. The basal medium used in this study
was DMEM, to which were added 10% of FBS and 1%
of antibiotic. The media were changed after three days
of incubation to ensure that the nutrients were sufficient
for cell growth and development. The cell proliferation
activity was observed daily until it reached approximately
80% confluence, at which time the cells were dissociated
from the media before cell seeding.
Viability test by the MTT assay. The MTT assay is a
colorimetric technique used to assess the cells’ metabolic
activity. Prior to the cell viability test, a hemocytometer
was used to count the cells following previous study.6
Using DMEM, approximately 1,000 cells (HT-29,
A375, and HGF-1) were aliquoted into different 12-well
plates containing 10% of FBS and 1% of antibiotic and
glucose. The 12-well plates of glucose were incubated
at the four distinct intervals of 1, 3, 5, and 10 days.
The treated cell lines in the well plates were washed
with phosphate buffer saline. Then, 20 µL of MTT
solution, with a concentration of 0.5 mg/mL, was added
to each well and incubated for at least two hours. The
MTT solution was removed but then received 200 µL of
dimethyl sulfoxide (DMSO) to solubilize the formazan
crystals. A spectrophotometer was used to measure the
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absorbance under a wavelength of 450 nm. All cell
viability processes were treated as light-sensitive and
wrapped in aluminum foil.
Data analysis. The data were analyzed using the
Statistical Package for the Social Sciences software. All
treated groups were compared with the control group.
The values were expressed as a standard error of the
mean ± standard deviation. Significant differences
between the treated groups and the control were
determined using one-way ANOVA. A p-value ≤ 0.05
was considered significant.

Results
The cell viability percentage of the normal human
gingival fibroblast (hGF) showed a rapid decline on Day
3, after treatment with glucose, whereby nearly 95% of
the cells decreased from Day 1. On Day 5, the normal
hGF’s cell viability showed a slight increase of around
2%. Finally, the cells continued to decline until Day 10.
In contrast, the control group showed a consistent
pattern from Day 1 to Day 3. The control group also
showed an increase above 100% on Day 5 and a decline
on Day 10 (Figure 1). The value of hGF treated with
glucose was less than 0.001, which is considered
significant (Table 1).
The cell viability percentage of the skin malignant
melanoma (A375) showed the potential to adapt when
treated with higher glucose. Overall, the pattern of all
treated and untreated groups showed an increase from
Day 1 until Day 5 and started to decline on Day 10,
except for the group treated with a concentration of 10
mg/ml. The cell viability percentage of the group treated
with 10 mg/ml of glucose decreased slightly on the third
day; however, it increased on Day 5 before declining on
Day 10. Among the treatment groups, the highest A375
cells viability percentage (above 100%) was on Day 5
of incubation (Figure 2). The value of A375 when
treated with higher glucose was less than 0.001, which
is considered significant (Table 1).
The pattern of the human colorectal adenocarcinoma
(HT29) cell viability, which was treated with glucose,
increased from Day 1 until Day 5, with a percentage of
above 100%. On Day 10, the HT29 cells rapidly fell to
38.8%, 44.1%, and 43.9%, according to the different
concentrations of 1 mg/mL, 5 mg/mL, and 10 mg/mL,
respectively. In contrast, the HT29 cells in the untreated
group consistently increased until Day 5 (144.5%) and
leveled off on Day 10. Among the treatment groups, the
highest cell viability percentage of HT29 occurred with
5 mg/mL of glucose concentration (Figure 3). The value
of HT29, when treated with higher glucose, was less
than 0.001, which is considered significant (Table 1).
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0
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Day 3
Day 5
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Day 10
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100
98.78100857
111.8049603
93.30624454

1 mg/ml
104.9828906
5.1633333
7.091111067
1.298275595

5 mg/ml
104.1274582
5.192222189
11.38888887
2.269558193

10 mg/ml
104.5124007
5.418888889
11.07222214
0.154227417

Day of Treatment
Figure 1. The percentage of HGF cells when treated with glucose of 1 mg/mL, 5 mg/mL, and 10 mg/mL for three intervals on Day 1,
Day 3, Day 5, and Day 10

Table 1. One-way ANOVA table of HGF-Glucose, A375-Glucose and HT29-Glucose
Sum of Squares

Df

Mean Square

F

p

HGF–Glucose
Between groups

0.062

15

0.004

Within groups
Total
A375–Glucose
Between groups
Within groups
Total
HT29–Glucose
Between groups
Within groups
Total

0.152
0.214

128
143

0.001

26.244
46.748
72.991

15
740
755

681621.025
734581.303
1416202.328

15
668
683

Makara J Health Res.

3.490

< 0.001

1.750
.063

27.695

< 0.001

45441.402
1099.673

41.323

<0.001
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Figure 2. The percentage of A375 cells when treated with glucose of 1 mg/mL, 5 mg/mL, and 10 mg/mL for three intervals on Day
1, Day 3, Day 5, and Day 10
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Figure 3. The percentage of HT29 cells when treated with glucose of 1 mg/mL, 5 mg/mL, and 10 mg/mL for three intervals on Day
1, Day 3, Day 5, and Day 10
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Discussion
Glucose is an essential source of energy for both
normal and cancer cells. It is very difficult to blame
glucose as a direct cause of cancer. However, glucose
may be associated with other factors, such as body
weight increase and physical inactivity. For instance, a
study reported that higher intake of sugar and sugarsweetened beverages may increase the risk of type I
endometrial cancers.9 In this study, the patterns of both
normal and cancer cells were investigated to detect any
possible differences between them.
The cell viability results showed that glucose
overconsumption can be toxic to the normal hGF cells.
In addition, the HT29 and A375 cells could survive
when treated with high glucose. The results also
indicated that the normal hGF cells experienced a
rapid decline after Day 1, while cancer cells (A375 and
HT29) could survive with a high glucose concentration.
The mitochondria was where the glucose was processed
to provide ATP, a form of energy that is important for
cellular activity.10 During ATP production, the free
radicals, alongside their by-products, were produced.11
The free radicals could induce oxidative stress, a
condition that causes an imbalance between the
production of free radicals and reactive oxygen species
(ROS) in the body.12 The effects of oxidative stress
vary; for example, mild oxidative stress is temporary
and tolerable, whereas chronic oxidative stress may
cause critical conditions, such as cancer and diabetes,
by severely damaging the structures and functions of
cells.13 In addition, the ROS imbalance could cause
normal cells to die by either necrosis or apoptosis. 14-15
In this study, the normal hGF cells were treated with
higher glucose. The treated groups’ pattern showed
that the percentage of the hGF cell viability declined
sharply from Day 3 onward. This trend could imply
that the normal hGF cells do not favor a high glucose
concentration, which causes cell death. Glucose
metabolism in mitochondria could synthesize the
protein whose function is to execute apoptosis. For
example, cytochrome c is involved in glucose
metabolism via the electron transport chain, which is
vital to the formation of apoptosome and the
progression of apoptosis.16 Elsewhere, it has also been
reported that high glucose-induced oxidative stress
could impair hGFs’ proliferation and migration.17
Therefore, oxidative stress might be the factor that
caused the hGF cell lines to suffer a rapid decline in
incubation after Day 1.
There is a fundamental difference between normal and
cancer cells. As noted earlier, the latter can grow
uncontrollably and become very invasive. 2 The A375
and HT29 cells, which had been treated with additional
Makara J Health Res.
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glucose, showed a similar pattern to that of the
untreated group. The growth pattern of all groups of
cells was, according to the four phases of lag,
exponential, stationary, and death. However, the group
that was treated with 10 mg/mL of glucose showed a
slight decrease on Day 3. Cancer cells can be very
adaptive to the high glucose-induced oxidative stress
condition. A study has reported that, under the oxidative
stress condition, the prostate-associated gene 4 (PAGE4)
expression also increases, which subsequently avoids
cancer cell apoptosis.18 PAGE4 is a highly intrinsically
disordered protein, whereas protein overexpression
could protect the cells from stress-induced death.19
Another study has reported that cancer cells can ignore
the signals that are important for preventing cell
division or the beginning of a process known as
“programmed cell death,” whereby the body tends to
dispose of its abnormal cells by increasing CD47
production.2 The CD47 protein is also known as
integrin-associated protein, which is encoded by the
CD47 gene.20 This CD47 protein will avoid normal
phagocytosis by binding to the receptor signalregulatory protein-α (SIRP-α) in macrophages.21 Hence,
this development could explain why the cancer cell
lines managed to survive in the higher glucose condition.

Conclusion
In conclusion, high glucose concentration can be toxic
to hGF cells. Also, the HT29 and A375 cells have the
potential to adapt to the hyperglycaemic condition.
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